The effect of midodrine, octreotide and albumin in patients with refractory ascites

dc.contributor.authorTandon, Puneeta
dc.date.accessioned2025-05-29T16:14:15Z
dc.date.available2025-05-29T16:14:15Z
dc.date.issued2007
dc.identifier.doihttps://doi.org/10.7939/r3-c9g1-jf04
dc.language.isoen
dc.rightsThis thesis is made available by the University of Alberta Libraries with permission of the copyright owner solely for the purpose of private, scholarly or scientific research. This thesis, or any portion thereof, may not otherwise be copied or reproduced without the written consent of the copyright owner, except to the extent permitted by Canadian copyright law.
dc.subjectAscites. Chemotherapy.
dc.subjectHepatorenal syndrome.
dc.subjectSympathomimetic agents. Therapeutic use.
dc.subjectOctreotide acetate. Therapeutic use.
dc.subjectAlbumins. Therapeutic use.
dc.titleThe effect of midodrine, octreotide and albumin in patients with refractory ascites
dc.typehttp://purl.org/coar/resource_type/c_46ec
thesis.degree.grantorhttp://id.loc.gov/authorities/names/n79058482
thesis.degree.levelMaster's
thesis.degree.nameMaster of Science
ual.date.graduation2007
ual.departmentDepartment of Public Health Sciences
ual.jupiterAccesshttp://terms.library.ualberta.ca/public

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
MR33358.pdf
Size:
1.97 MB
Format:
Adobe Portable Document Format